
Stivrox CV 500mg/125mg Tablet
Marketer
Indoscot Healthcare LLP
Salt Composition
Cefuroxime (500mg) + Clavulanic Acid (125mg)
Overview Stivrox CV 500mg/125mg Tablet
Combiflox 500mg/125mg tablets combat bacterial infections by inhibiting microbial proliferation. This prescription medication, taken as directed, may be ingested with or without food, but consistently timed administration optimizes effectiveness. Exceeding the prescribed dosage can be detrimental. Missed doses should be taken upon recollection. Complete the full course of treatment, even with symptom improvement; premature cessation compromises efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Seek immediate medical help for allergic reactions (e.g., rash, itching, swelling, dyspnea). Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if experiencing somnolence or dizziness. Adequate rest, a balanced diet, and ample hydration are vital for optimal recovery. Your doctor may order laboratory tests to monitor treatment response.
Uses of Stivrox CV 500mg/125mg Tablet
Managing bacterial infections
Major Benefits of Stivrox CV 500mg/125mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Stivrox CV 500mg/125mg Tablets. Ingest the tablets whole; avoid crushing, chewing, or breaking them. These tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Stivrox CV 500mg/125mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Increased liver enzymes
- Allergic reaction
How to use Stivrox CV 500mg/125mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Stivrox CV 500mg/125mg Tablet whole; avoid chewing, crushing, or breaking it. Consumption may coincide with meals or not, but consistency in timing is recommended.
How Stivrox CV 500mg/125mg Tablet works:
Stivrox CV 500mg/125mg tablets contain Cefuroxime, an antibiotic, and Clavulanic Acid, a beta-lactamase inhibitor. Cefuroxime combats bacterial infection by disrupting the synthesis of their protective cell walls, hindering their survival. Clavulanic Acid counteracts bacterial enzymes that would otherwise neutralize Cefuroxime, thus boosting its effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Stivrox CV 500mg/125mg Tablet and alcohol.
PregnancySAFE IF PRESCRIBED
Use of Stivrox CV 500mg/125mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harm to fetal development; however, data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
Stivrox CV 500mg/125mg tablets pose minimal risk during lactation. Research in humans indicates negligible transfer into breast milk, posing no known harm to the infant.
DrivingNOT RELEVANT
Inapplicable, given that Stivrox CV 500mg/125mg Tablets are prescribed solely for inpatients.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Stivrox CV 500mg/125mg tablets to individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Stivrox CV 500mg/125mg tablets in individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Stivrox CV 500mg/125mg Tablet :
Should you forget a Stivrox CV 500mg/125mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Stivrox CV 500mg/125mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
